False negatives have profiles closer to non-NASH patients for several key features, including those suggesting normal liver health (AST, ALT, and albumin closer to or within normal range), normal metabolic function (HbA1C in normal range), or less inflammation (normal total protein). This evidence concerns the gene GPT and metabolic dysfunction-associated steatohepatitis.